Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.2600
-0.0399 (-13.30%)
May 12, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is July - June.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Contract Manufacturing
48.57M
Log In
Log In
Log In
Log In
Contract Manufacturing Growth
0.60%
Log In
Log In
Log In
Log In
Other Nutraceutical Businesses
1.75M
Log In
Log In
Log In
Log In
Other Nutraceutical Businesses Growth
-26.97%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is July - June.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
United States
42.34M
Log In
Log In
Log In
Log In
United States Growth
-0.64%
Log In
Log In
Log In
Log In
International
7.97M
Log In
Log In
Log In
Log In
International Growth
-1.02%
Log In
Log In
Log In
Log In